| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/25/2023 | Neuronetics, Inc. | STIM | Grant | Common Stock | 36.4k | $0.00 | $0 | | 05/25/2023 |
| 03/06/2023 | CONCERT PHARMACEUTICALS, INC. | CNCE | Disposition | Stock Option (Right to Buy) | 10k | $16.42 | $164.2k | | 03/06/2023 |
| 03/06/2023 | CONCERT PHARMACEUTICALS, INC. | CNCE | Disposition | Stock Option (Right to Buy) | 10k | $12.96 | $129.6k | | 03/06/2023 |
| 03/06/2023 | CONCERT PHARMACEUTICALS, INC. | CNCE | Disposition | Stock Option (Right to Buy) | 10k | $13.29 | $132.9k | | 03/06/2023 |
| 03/06/2023 | CONCERT PHARMACEUTICALS, INC. | CNCE | Disposition | Stock Option (Right to Buy) | 10k | $19.59 | $195.9k | | 03/06/2023 |
| 03/06/2023 | CONCERT PHARMACEUTICALS, INC. | CNCE | Disposition | Stock Option (Right to Buy) | 10k | $11.02 | $110.2k | | 03/06/2023 |
| 03/06/2023 | CONCERT PHARMACEUTICALS, INC. | CNCE | Other | Common Stock | 5.1k | $0.00 | $0 | | 03/06/2023 |
| 03/06/2023 | CONCERT PHARMACEUTICALS, INC. | CNCE | Disposition | Common Stock | 16.4k | $0.00 | $0 | | 03/06/2023 |
| 03/06/2023 | CONCERT PHARMACEUTICALS, INC. | CNCE | Disposition | Stock Option (Right to Buy) | 10k | $9.16 | $91.6k | | 03/06/2023 |
| 03/06/2023 | CONCERT PHARMACEUTICALS, INC. | CNCE | Disposition | Stock Option (Right to Buy) | 10.2k | $4.26 | $43.7k | | 03/06/2023 |
| 06/09/2022 | CONCERT PHARMACEUTICALS, INC. | CNCE | Grant | Common Stock | 16.4k | $0.00 | $0 | | 06/09/2022 |
| 05/26/2022 | Neuronetics, Inc. | STIM | Grant | Common Stock | 38.9k | $0.00 | $0 | | 05/26/2022 |
| 06/10/2021 | CONCERT PHARMACEUTICALS, INC. | CNCE | Grant | Stock Option (right to buy) | 10.2k | $4.26 | $43.7k | | 06/10/2021 |
| 06/10/2021 | CONCERT PHARMACEUTICALS, INC. | CNCE | Grant | Common Stock | 5.1k | $0.00 | $0 | | 06/10/2021 |
| 05/27/2021 | Neuronetics, Inc. | STIM | Grant | Common Stock | 7.1k | $0.00 | $0 | | 05/27/2021 |
| 08/05/2020 | Neuronetics, Inc. | STIM | Grant | Common Stock | 18.5k | $0.00 | $0 | | 08/05/2020 |
| 06/11/2020 | CONCERT PHARMACEUTICALS, INC. | CNCE | Grant | Stock Option (right to buy) | 10k | $9.16 | $91.6k | | 06/11/2020 |
| 05/26/2020 | Neuronetics, Inc. | STIM | Grant | Common Stock | 20k | $0.00 | $0 | | 05/26/2020 |
| 05/21/2020 | NEVRO CORP | NVRO | Grant | Common Stock | 1.4k | $0.00 | $0 | | 05/21/2020 |
| 01/02/2020 | Neuronetics, Inc. | STIM | Grant | Common Stock | 3.1k | $4.49 | $13.7k | | 01/02/2020 |
| 10/01/2019 | Neuronetics, Inc. | STIM | Grant | Common Stock | 2k | $8.30 | $16.2k | | 10/01/2019 |
| 06/13/2019 | CONCERT PHARMACEUTICALS, INC. | CNCE | Grant | Nonstatutory Stock Option (Right to Buy) | 10k | $11.02 | $110.2k | | 06/13/2019 |
| 05/28/2019 | Neuronetics, Inc. | STIM | Grant | Common Stock | 3.7k | $0.00 | $0 | | 05/28/2019 |
| 05/28/2019 | Neuronetics, Inc. | STIM | Grant | Stock Option (right to buy) | 7.3k | $13.43 | $98.7k | | 05/28/2019 |
| 05/20/2019 | NEVRO CORP | NVRO | Grant | Common Stock | 2.9k | $0.00 | $0 | | 05/20/2019 |
| 04/01/2019 | Neuronetics, Inc. | STIM | Grant | Common Stock | 932 | $14.75 | $13.7k | | 04/01/2019 |
| 07/02/2018 | Neuronetics, Inc. | STIM | Purchase | Common Stock | 6.7k | $17.00 | $113.3k | | 07/02/2018 |
| 07/02/2018 | Neuronetics, Inc. | STIM | Grant | Stock Option (Right to Buy) | 8.8k | $5.22 | $45.8k | | 07/02/2018 |
| 06/14/2018 | CONCERT PHARMACEUTICALS, INC. | CNCE | Grant | Nonstatutory Stock Option (Right to Buy) | 10k | $19.59 | $195.9k | | 06/14/2018 |
| 05/21/2018 | NEVRO CORP | NVRO | Grant | Common Stock | 3.8k | $0.00 | $0 | | 05/21/2018 |
| 03/07/2018 | NEVRO CORP | NVRO | Sale | Common Stock | 66.1k | $81.42 | $5.4M | See footnote | 03/05/2018 |
| 03/07/2018 | NEVRO CORP | NVRO | Sale | Common Stock | 1.5k | $81.42 | $119k | See footnote | 03/05/2018 |
| 03/06/2018 | NEVRO CORP | NVRO | Sale | Common Stock | 49.7k | $80.38 | $4M | See footnote | 03/05/2018 |
| 03/06/2018 | NEVRO CORP | NVRO | Sale | Common Stock | 1.1k | $80.38 | $88.3k | See footnote | 03/05/2018 |
| 03/05/2018 | NEVRO CORP | NVRO | Sale | Common Stock | 41.2k | $80.19 | $3.3M | See footnote | 03/05/2018 |
|